Telix Pharmaceuticals and Radboud University Medical Centre Conclude Clinical Collaboration Agreement
March 14, 2018 19:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and NIJMEGAN, The Netherlands, March 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company...
Telix Pharmaceuticals Establishes Japanese Subsidiary, Appoints Key Executives
January 14, 2018 21:12 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and KYOTO Japan, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the...
Telix Pharmaceuticals and Memorial Sloan Kettering Cancer Center Announce Renal Cancer Collaboration
December 13, 2017 17:30 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and NEW YORK, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the...
Telix Pharmaceuticals and JFE Announce Japanese Radiopharmaceutical Manufacturing Partnership
December 12, 2017 17:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and TOKYO, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development...
Telix Pharmaceuticals Appointed Dr. Bernard Lambert as President of Telix Pharmaceuticals (US) Inc.
December 03, 2017 17:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the...
Telix Pharmaceuticals Limited Lists on the Australian Securities Exchange
November 14, 2017 20:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of...
Telix Pharmaceuticals Limited Successfully Completes $50 Million Oversubscribed Initial Public Offering
November 08, 2017 18:20 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagnostic and...
Telix Pharmaceuticals and ANMI Partner for Prostate Cancer Imaging
October 23, 2017 19:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and LIÈGE, Belgium, Oct. 24, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (Telix, Company), a clinical-stage biopharmaceutical company focused on the development...
Telix Pharmaceuticals Limited Launches $50 Million Underwritten Initial Public Offering (ASX: TLX)
October 23, 2017 17:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Oct. 24, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (Telix, the Company), an Australian biopharmaceutical company focused on the development of diagnostic and...
University of Melbourne and Telix Pharmaceuticals Establish Cancer Translational Research Partnership
October 17, 2017 17:18 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagnostic and...